U.S., Nov. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07950527) titled 'Topical Insulin Therapy for Persistent Corneal Epithelial Defects' on Nov. 09.
Brief Summary: The goal of this clinical trial is to learn if insulin eye drops, added to standard care, can treat persistent corneal epithelial defects (PEDs) in adults age 18 and older. A PED is a corneal surface wound, at least 2 mm across, that has not healed after more than 14 days of standard treatment such as lubricants, antibiotic drops, or a bandage contact lens. The main question it aims to answer is:
- Does adding insulin eye drops (1 IU/mL, four times daily) to standard care increase the proportion of eyes with complete corneal epithelial hea...